UNSPSC 51351514: Progesterone

This classification denotes a progestagen with the molecular formula C21H30O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4G7DS2Q64Y, chemically known as 10.alpha.-pregn-4-ene-3,20-dione but generally known as progesterone, which bears US NIH Compound Identifier 4920. European Medicines Agency schedules Progesterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10076MIG.

UNSPSC 51351514 Progesterone, a Commodity code, covers the procurement of progesterone pharmaceuticals by state and local health agencies, correctional systems, and public medical facilities. State and local governments purchase progesterone in formulations ranging from oral tablets and capsules to injectable solutions and transdermal preparations, typically as part of routine pharmaceutical inventory for hormone replacement therapy, contraception, pregnancy support, and menstrual disorder management. Purchasing bodies include state departments of health, county public health departments, municipal hospital systems, and state correctional healthcare divisions. Procurement typically occurs through standing pharmaceutical supply contracts, cooperative purchasing agreements with multi-state pharmacy networks, and competitive sealed bidding for specific formulations and quantities.

The source provided contains no recent state and local contract opportunities under this code, so current geographic distribution and representative recent solicitations cannot be characterized from available data. Vendors pursuing this Commodity should monitor state health department procurement portals and cooperative purchasing catalogs (such as NASPO ValuePoint or regional health purchasing consortia) for ongoing pharmaceutical supply solicitations, as progesterone contracts are frequently bundled within broader hormone and reproductive-health medication line items or awarded through standing-price agreements rather than individual project-specific RFPs.